{
    "nctId": "NCT02318446",
    "officialTitle": "Efficacy Study of Folic Acid Supplementation on Homocysteine Levels in Adolescent Epileptics Taking Antiepileptic Drugs: A Single Blind Randomized Controlled Clinical Trial",
    "inclusionCriteria": "* Diagnosed epileptic patients of either sex with age between 10-19 yrs (\\<19yrs), coming to the medicine Out Patient /In Patient Departments and undergoing AED therapy for more than 6 months.\n* Epileptics with high homocysteine levels i.e. \\> 10.9 \u00b5mol/L (Normal homocysteine levels are 4.3-9.9 \u00b5mol/L for male and 3.3-7.2 \u00b5mol/L for female adolescent and a high homocysteine concentration is deaned as at least 11.4 \u00b5mol/L for male and at least 10.4 \u00b5mol/L for female. Gender mean of high homocysteine concentration is 10.9 \u00b5mol/L) \\[5\\]\n* Must have minimum age of 10 Years\n* Must have maximum age of 19 Years",
    "exclusionCriteria": "* Pregnancy and lactation\n* Patients with diabetes, Ischemic heart disease (IHD), stroke, malignancy and psychiatric diseases are excluded from study.\n* The patients receiving vitamin supplements or who had clinical evidence for an acute illness, renal dysfunction, thyroid dysfunction, chronic inflammatory diseases, inborn errors of homocysteine, cobalamin or folate metabolism, or any other condition known to interfere with homocysteine metabolism will be excluded\n* Patients who are already involved in any other trial.\n* Patients not willing to fill consent/ assent form are also excluded from study."
}